Health news and commentary gathered by MedPage Today staff ...

GLP-1 agonist market expected to grow from $70B in 2025 to $201B in 20301Proprietary Forzet formulation provides ...

New research indicates medications like Ozempic and Wegovy could be linked to higher risks of fractures, osteoporosis, and gout in older adults—though experts say the benefits of these drugs may still ...

New research suggests GLP-1 drugs may increase the risk of bone and tendon injuries and other conditions, including ...

The effect was seen across a wide variety of addictive and habit-forming substances, including cocaine, opioids, alcohol, ...

New study suggests GLP-1 drugs like Ozempic and Wegovy may raise fracture risk by 11% in adults 65 and older with type 2 ...

The companies have been embroiled in a row about compounded GLP-1 drugs that escalated to a lawsuit last month. The legal action has now been dropped and the former adversaries have struck a deal that ...

GLP-1 drugs may help boost heart attack recovery by lowering the risk of major complications, an animal study suggests.

Diabetes and obesity drugs also lead to large reductions in adverse cardiovascular events, and the benefits aren’t just down ...

A large study of data from Veterans Affairs finds that people on GLP-1 drugs were less likely to develop substance abuse disorder or overdose.

Drug executives say only their GLP-1 drugs are safe for treating obesity and diabetes as they wage a year-long campaign to ...

Researchers at Washington University School of Medicine in St. Louis show in a new study that GLP-1 medications may be ...